Preclinical Imaging Market Size, Share, and Analysis, By Product (Optical Imaging, PET, SPECT, Optical Imaging Reagents, Contrast Agents, and Nuclear Imaging Reagents), By Application (Oncology, Neurology, and Others), By End-User (Pharmaceutical, Imaging Centers, and Others), By Region (North America, Europe, Asia-Pacific, and Rest of the World), And Regional Forecast 2024-2034
Preclinical Imaging Market Size, Share, and Analysis, By Product (Optical Imaging, PET, SPECT, Optical Imaging Reagents, Contrast Agents, and Nuclear Imaging Reagents), By Application (Oncology, Neurology, and Others), By End-User (Pharmaceutical, Imaging Centers, and Others), By Region (North America, Europe, Asia-Pacific, and Rest of the World), And Regional Forecast 2024-2034
PRODUCT OVERVIEW
Preclinical Imaging Market is anticipated to exhibit a Compound Annual Growth Rate (CAGR) of 5% during the forecast span from 2024 to 2034. In 2023, the market size was assessed at USD 2.8 billion and is projected to reach USD 4.7 billion by the completion of 2034.
Preclinical imaging is a branch of medical imaging that studies biological procedures and disorders in tiny animal models, like mice or rats, before performing human trials. Various imaging techniques, such as MRI, PET, CT, and optical imaging, are used to visualize anatomical features, molecular interactions, and physiological activities at the cellular and molecular levels. Additionally, scientists can use non-invasive imaging techniques to track the progression of disease, assess the efficacy of treatment, and study the underlying causes of illness. Preclinical imaging is important in drug development as it allows researchers to assess new treatments, along with understanding their pharmacokinetics and pharmacodynamics, and make informed decisions before moving on to human trials. As a result, preclinical imaging provides an important link between fundamental research and practical medical applications, as it helps in the transitioning of new treatments.
MARKET HIGHLIGHTS
Preclinical Imaging Market is projected to reach USD 4.7 billion over the forecast period, due to the growth in research & development efforts in the pharmaceutical and biotechnology sectors. The enhanced technology of imaging modalities such as MRI, PET, SPECT, and CT has increased their ability to study molecular and cellular processes in small animal models. In addition, the rising need for personalized medicine and accurate treatments has led to high investment in preclinical imaging for drug discovery and development. Moreover, the increasing occurrence of chronic illnesses such as cancer and neurological disorders highlights the importance of gaining a deeper understanding of disease mechanisms, which further promotes the adoption of preclinical imaging. Therefore, the preclinical imaging market is expected to grow due to the growing use of advanced imaging technologies and the higher investment in biomedical research.
Preclinical Imaging Market Segments:
Growth Drivers
Advancements in Preclinical Imaging Technology to Drive Growth in the Preclinical Imaging Market
Increasing Prevalence of Chronic Diseases Act as a Catalyst for Market Growth
Restraint
Cost of Equipment and Maintenance in the Preclinical Imaging Market Will Impact the Growth
Key Players
PRODUCT OVERVIEW
Preclinical Imaging Market is anticipated to exhibit a Compound Annual Growth Rate (CAGR) of 5% during the forecast span from 2024 to 2034. In 2023, the market size was assessed at USD 2.8 billion and is projected to reach USD 4.7 billion by the completion of 2034.
Preclinical imaging is a branch of medical imaging that studies biological procedures and disorders in tiny animal models, like mice or rats, before performing human trials. Various imaging techniques, such as MRI, PET, CT, and optical imaging, are used to visualize anatomical features, molecular interactions, and physiological activities at the cellular and molecular levels. Additionally, scientists can use non-invasive imaging techniques to track the progression of disease, assess the efficacy of treatment, and study the underlying causes of illness. Preclinical imaging is important in drug development as it allows researchers to assess new treatments, along with understanding their pharmacokinetics and pharmacodynamics, and make informed decisions before moving on to human trials. As a result, preclinical imaging provides an important link between fundamental research and practical medical applications, as it helps in the transitioning of new treatments.
MARKET HIGHLIGHTS
Preclinical Imaging Market is projected to reach USD 4.7 billion over the forecast period, due to the growth in research & development efforts in the pharmaceutical and biotechnology sectors. The enhanced technology of imaging modalities such as MRI, PET, SPECT, and CT has increased their ability to study molecular and cellular processes in small animal models. In addition, the rising need for personalized medicine and accurate treatments has led to high investment in preclinical imaging for drug discovery and development. Moreover, the increasing occurrence of chronic illnesses such as cancer and neurological disorders highlights the importance of gaining a deeper understanding of disease mechanisms, which further promotes the adoption of preclinical imaging. Therefore, the preclinical imaging market is expected to grow due to the growing use of advanced imaging technologies and the higher investment in biomedical research.
Preclinical Imaging Market Segments:
- By Product
- Optical Imaging
- PET
- SPECT
- Optical Imaging Reagents
- Contrast Agents
- Nuclear Imaging Reagents
- By Application
- Oncology
- Neurology
- Others
- By End-User
- Pharmaceutical
- Imaging Centers
- Others
Growth Drivers
Advancements in Preclinical Imaging Technology to Drive Growth in the Preclinical Imaging Market
Increasing Prevalence of Chronic Diseases Act as a Catalyst for Market Growth
Restraint
Cost of Equipment and Maintenance in the Preclinical Imaging Market Will Impact the Growth
Key Players
- Bruker Corporation
- PerkinElmer, Inc.
- Siemens Healthineers AG
- GE Healthcare
- MR Solutions
- Aspect Imaging Ltd.
- Mediso Medical Imaging Systems
- MILabs B.V.
- TriFoil Imaging
- Agilent Technologies, Inc.
- Fujifilm Holdings Corporation
- Thermo Fisher Scientific Inc.
- Miltenyi Biotec
- LI-COR Biosciences
- Perceptive Instruments Ltd.
- Other Prominent Players (Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis)
- North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAG.R – United States and Canada
- Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil and Rest of Latin America
- Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey and Rest of Europe
- Asia Pacific Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia and Rest of APAC
- Middle East and Africa Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa and Rest of MENA
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 3-month post-sales analyst support.
1.EXECUTIVE SUMMARY
1.1. Regional Market Share
1.2.Business Trends
1.3. Preclinical Imaging Market: COVID-19 Outbreak
1.4. Regional Trends
1.5. Segmentation Snapshot
2. RESEARCH METHODOLOGY
2.1.Research Objective
2.2. Research Approach
2.3. Data Sourcing and Methodology
2.4.Primary Research
2.5.Secondary Research
2.5.1.Paid Sources
2.5.2. Public Sources
2.6. Market Size Estimation and Data Triangulation
3. MARKET CHARACTERISTICS
3.1.Market Definition
3.2.Preclinical Imaging Market: COVID-19 Impact
3.3. Key Segmentations
3.4.Key Developments
3.5.Allied Industry Data
4.PRECLINICAL IMAGING MARKET – INDUSTRY INSIGHTS
4.1. Industry Segmentation
4.2.COVID-19 overview of world economy
4.3.Industry Ecosystem Channel Analysis
4.4.Innovation & Sustainability
5. MACROECONOMIC INDICATORS
6. RECENT DEVELOPMENTS
7. MARKET DYNAMICS
7.1.Introduction
7.2. Growth Drivers
7.3. Market Opportunities
7.4.Market Restraints
7.5. Market Trends
8.RISK ANALYSIS
9. MARKET ANALYSIS
9.1.Porter's Five Forces
9.2. PEST Analysis
9.2.1.Political
9.2.2. Economic
9.2.3. Social
9.2.4. Technological
10.PRECLINICAL IMAGING MARKET
10.1.Overview
10.2. Historical Analysis (2019-2022)
10.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast
11. PRECLINICAL IMAGING MARKET SIZE & FORECAST 2024A-2034F
11.1. Overview
11.2.Key Findings
11.3.Market Segmentation
11.3.1. By Product
11.3.1.1. Optical Imaging
11.3.1.1.1.By Value (USD Million) 2024-2034F
11.3.1.1.2. Market Share (%) 2024-2034F
11.3.1.1.3. Y-o-Y Growth (%) 2024-2034F
11.3.1.2.PET
11.3.1.2.1. By Value (USD Million) 2024-2034F
11.3.1.2.2.Market Share (%) 2024-2034F
11.3.1.2.3.Y-o-Y Growth (%) 2024-2034F
11.3.1.3.SPECT
11.3.1.3.1. By Value (USD Million) 2024-2034F
11.3.1.3.2.Market Share (%) 2024-2034F
11.3.1.3.3.Y-o-Y Growth (%) 2024-2034F
11.3.1.4.Optical Imaging Reagents
11.3.1.4.1. By Value (USD Million) 2024-2034F
11.3.1.4.2.Market Share (%) 2024-2034F
11.3.1.4.3.Y-o-Y Growth (%) 2024-2034F
11.3.1.5.Contrast Agents
11.3.1.5.1. By Value (USD Million) 2024-2034F
11.3.1.5.2.Market Share (%) 2024-2034F
11.3.1.5.3.Y-o-Y Growth (%) 2024-2034F
11.3.1.6.Nuclear Imaging Reagents
11.3.1.6.1. By Value (USD Million) 2024-2034F
11.3.1.6.2.Market Share (%) 2024-2034F
11.3.1.6.3.Y-o-Y Growth (%) 2024-2034F
11.3.2. By Application
11.3.2.1.Oncology
11.3.2.1.1. By Value (USD Million) 2024-2034F
11.3.2.1.2.Market Share (%) 2024-2034F
11.3.2.1.3.Y-o-Y Growth (%) 2024-2034F
11.3.2.2. Neurology
11.3.2.2.1.By Value (USD Million) 2024-2034F
11.3.2.2.2. Market Share (%) 2024-2034F
11.3.2.2.3. Y-o-Y Growth (%) 2024-2034F
11.3.2.3. Others
11.3.2.3.1.By Value (USD Million) 2024-2034F
11.3.2.3.2. Market Share (%) 2024-2034F
11.3.2.3.3. Y-o-Y Growth (%) 2024-2034F
11.3.3.By End-User
11.3.3.1.Pharmaceutical
11.3.3.1.1. By Value (USD Million) 2024-2034F
11.3.3.1.2.Market Share (%) 2024-2034F
11.3.3.1.3.Y-o-Y Growth (%) 2024-2034F
11.3.3.2. Imaging Centers
11.3.3.2.1.By Value (USD Million) 2024-2034F
11.3.3.2.2. Market Share (%) 2024-2034F
11.3.3.2.3. Y-o-Y Growth (%) 2024-2034F
11.3.3.3. Others
11.3.3.3.1.By Value (USD Million) 2024-2034F
11.3.3.3.2. Market Share (%) 2024-2034F
11.3.3.3.3. Y-o-Y Growth (%) 2024-2034F
12.NORTH AMERICA PRECLINICAL IMAGING MARKET SIZE & FORECAST 2024A-2034F
12.1.Overview
12.2. Key Findings
12.3. Market Segmentation
12.3.1.By Product
12.3.2. By Application
12.3.3. By End-User
12.4. Country
12.4.1. United States
12.4.2.Canada
13.EUROPE PRECLINICAL IMAGING MARKET SIZE & FORECAST 2024A-2034F
13.1.Overview
13.2. Key Findings
13.3. Market Segmentation
13.3.1.By Product
13.3.2. By Application
13.3.3. By End-User
13.4.Country
13.4.1.Germany
13.4.2. United Kingdom
13.4.3. France
13.4.4. Italy
13.4.5. Spain
13.4.6. Russia
13.4.7. Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)
14.ASIA-PACIFIC PRECLINICAL IMAGING MARKET SIZE & FORECAST 2024A-2034F
14.1. Overview
14.2. Key Findings
14.3.Market Segmentation
14.3.1.By Product
14.3.2. By Application
14.3.3. By End-User
14.4.Country
14.4.1. India
14.4.2. China
14.4.3. South Korea
14.4.4.Japan
14.4.5.Rest of APAC
15.MIDDLE EAST AND AFRICA PRECLINICAL IMAGING MARKET SIZE & FORECAST 2024A-2034F
15.1.Overview
15.2. Key Findings
15.3. Market Segmentation
15.3.1.By Product
15.3.2. By Application
15.3.3. By End-User
15.4.Country
15.4.1. Israel
15.4.2.GCC
15.4.3.North Africa
15.4.4.South Africa
15.4.5.Rest of Middle East and Africa
16. LATIN AMERICA PRECLINICAL IMAGING MARKET SIZE & FORECAST 2024A-2034F
16.1.Overview
16.2. Key Findings
16.3. Market Segmentation
16.3.1.By Product
16.3.2. By Application
16.3.3. By End-User
16.4. Country
16.4.1. Mexico
16.4.2.Brazil
16.4.3.Rest of Latin America
17. COMPETITIVE LANDSCAPE
17.1.Company market share, 2023
17.2. Key player overview
17.3. Key stakeholders
18. COMPANY PROFILES
18.1. Bruker Corporation
18.1.1.Company Overview
18.1.2.Financial Overview
18.1.3.Key Product; Analysis
18.1.4.Company Assessment
18.1.4.1.Product Portfolio
18.1.4.2.Key Clients
18.1.4.3. Market Share
18.1.4.4. Recent News & Development (Last 3 Yrs.)
18.1.4.5. Executive Team
18.2.PerkinElmer, Inc.
18.3.Siemens Healthineers AG
18.4. GE Healthcare
18.5. MR Solutions
18.6.Aspect Imaging Ltd.
18.7.Mediso Medical Imaging Systems
18.8. MILabs B.V.
18.9.TriFoil Imaging
18.10.Agilent Technologies, Inc.
18.11. Fujifilm Holdings Corporation
18.12.Thermo Fisher Scientific Inc.
18.13.Miltenyi Biotec
18.14.LI-COR Biosciences
18.15.Perceptive Instruments Ltd.
18.16.Other Prominent Players
19. APPENDIX
20.CONSULTANT RECOMMENDATION
1.1. Regional Market Share
1.2.Business Trends
1.3. Preclinical Imaging Market: COVID-19 Outbreak
1.4. Regional Trends
1.5. Segmentation Snapshot
2. RESEARCH METHODOLOGY
2.1.Research Objective
2.2. Research Approach
2.3. Data Sourcing and Methodology
2.4.Primary Research
2.5.Secondary Research
2.5.1.Paid Sources
2.5.2. Public Sources
2.6. Market Size Estimation and Data Triangulation
3. MARKET CHARACTERISTICS
3.1.Market Definition
3.2.Preclinical Imaging Market: COVID-19 Impact
3.3. Key Segmentations
3.4.Key Developments
3.5.Allied Industry Data
4.PRECLINICAL IMAGING MARKET – INDUSTRY INSIGHTS
4.1. Industry Segmentation
4.2.COVID-19 overview of world economy
4.3.Industry Ecosystem Channel Analysis
4.4.Innovation & Sustainability
5. MACROECONOMIC INDICATORS
6. RECENT DEVELOPMENTS
7. MARKET DYNAMICS
7.1.Introduction
7.2. Growth Drivers
7.3. Market Opportunities
7.4.Market Restraints
7.5. Market Trends
8.RISK ANALYSIS
9. MARKET ANALYSIS
9.1.Porter's Five Forces
9.2. PEST Analysis
9.2.1.Political
9.2.2. Economic
9.2.3. Social
9.2.4. Technological
10.PRECLINICAL IMAGING MARKET
10.1.Overview
10.2. Historical Analysis (2019-2022)
10.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast
11. PRECLINICAL IMAGING MARKET SIZE & FORECAST 2024A-2034F
11.1. Overview
11.2.Key Findings
11.3.Market Segmentation
11.3.1. By Product
11.3.1.1. Optical Imaging
11.3.1.1.1.By Value (USD Million) 2024-2034F
11.3.1.1.2. Market Share (%) 2024-2034F
11.3.1.1.3. Y-o-Y Growth (%) 2024-2034F
11.3.1.2.PET
11.3.1.2.1. By Value (USD Million) 2024-2034F
11.3.1.2.2.Market Share (%) 2024-2034F
11.3.1.2.3.Y-o-Y Growth (%) 2024-2034F
11.3.1.3.SPECT
11.3.1.3.1. By Value (USD Million) 2024-2034F
11.3.1.3.2.Market Share (%) 2024-2034F
11.3.1.3.3.Y-o-Y Growth (%) 2024-2034F
11.3.1.4.Optical Imaging Reagents
11.3.1.4.1. By Value (USD Million) 2024-2034F
11.3.1.4.2.Market Share (%) 2024-2034F
11.3.1.4.3.Y-o-Y Growth (%) 2024-2034F
11.3.1.5.Contrast Agents
11.3.1.5.1. By Value (USD Million) 2024-2034F
11.3.1.5.2.Market Share (%) 2024-2034F
11.3.1.5.3.Y-o-Y Growth (%) 2024-2034F
11.3.1.6.Nuclear Imaging Reagents
11.3.1.6.1. By Value (USD Million) 2024-2034F
11.3.1.6.2.Market Share (%) 2024-2034F
11.3.1.6.3.Y-o-Y Growth (%) 2024-2034F
11.3.2. By Application
11.3.2.1.Oncology
11.3.2.1.1. By Value (USD Million) 2024-2034F
11.3.2.1.2.Market Share (%) 2024-2034F
11.3.2.1.3.Y-o-Y Growth (%) 2024-2034F
11.3.2.2. Neurology
11.3.2.2.1.By Value (USD Million) 2024-2034F
11.3.2.2.2. Market Share (%) 2024-2034F
11.3.2.2.3. Y-o-Y Growth (%) 2024-2034F
11.3.2.3. Others
11.3.2.3.1.By Value (USD Million) 2024-2034F
11.3.2.3.2. Market Share (%) 2024-2034F
11.3.2.3.3. Y-o-Y Growth (%) 2024-2034F
11.3.3.By End-User
11.3.3.1.Pharmaceutical
11.3.3.1.1. By Value (USD Million) 2024-2034F
11.3.3.1.2.Market Share (%) 2024-2034F
11.3.3.1.3.Y-o-Y Growth (%) 2024-2034F
11.3.3.2. Imaging Centers
11.3.3.2.1.By Value (USD Million) 2024-2034F
11.3.3.2.2. Market Share (%) 2024-2034F
11.3.3.2.3. Y-o-Y Growth (%) 2024-2034F
11.3.3.3. Others
11.3.3.3.1.By Value (USD Million) 2024-2034F
11.3.3.3.2. Market Share (%) 2024-2034F
11.3.3.3.3. Y-o-Y Growth (%) 2024-2034F
12.NORTH AMERICA PRECLINICAL IMAGING MARKET SIZE & FORECAST 2024A-2034F
12.1.Overview
12.2. Key Findings
12.3. Market Segmentation
12.3.1.By Product
12.3.2. By Application
12.3.3. By End-User
12.4. Country
12.4.1. United States
12.4.2.Canada
13.EUROPE PRECLINICAL IMAGING MARKET SIZE & FORECAST 2024A-2034F
13.1.Overview
13.2. Key Findings
13.3. Market Segmentation
13.3.1.By Product
13.3.2. By Application
13.3.3. By End-User
13.4.Country
13.4.1.Germany
13.4.2. United Kingdom
13.4.3. France
13.4.4. Italy
13.4.5. Spain
13.4.6. Russia
13.4.7. Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)
14.ASIA-PACIFIC PRECLINICAL IMAGING MARKET SIZE & FORECAST 2024A-2034F
14.1. Overview
14.2. Key Findings
14.3.Market Segmentation
14.3.1.By Product
14.3.2. By Application
14.3.3. By End-User
14.4.Country
14.4.1. India
14.4.2. China
14.4.3. South Korea
14.4.4.Japan
14.4.5.Rest of APAC
15.MIDDLE EAST AND AFRICA PRECLINICAL IMAGING MARKET SIZE & FORECAST 2024A-2034F
15.1.Overview
15.2. Key Findings
15.3. Market Segmentation
15.3.1.By Product
15.3.2. By Application
15.3.3. By End-User
15.4.Country
15.4.1. Israel
15.4.2.GCC
15.4.3.North Africa
15.4.4.South Africa
15.4.5.Rest of Middle East and Africa
16. LATIN AMERICA PRECLINICAL IMAGING MARKET SIZE & FORECAST 2024A-2034F
16.1.Overview
16.2. Key Findings
16.3. Market Segmentation
16.3.1.By Product
16.3.2. By Application
16.3.3. By End-User
16.4. Country
16.4.1. Mexico
16.4.2.Brazil
16.4.3.Rest of Latin America
17. COMPETITIVE LANDSCAPE
17.1.Company market share, 2023
17.2. Key player overview
17.3. Key stakeholders
18. COMPANY PROFILES
18.1. Bruker Corporation
18.1.1.Company Overview
18.1.2.Financial Overview
18.1.3.Key Product; Analysis
18.1.4.Company Assessment
18.1.4.1.Product Portfolio
18.1.4.2.Key Clients
18.1.4.3. Market Share
18.1.4.4. Recent News & Development (Last 3 Yrs.)
18.1.4.5. Executive Team
18.2.PerkinElmer, Inc.
18.3.Siemens Healthineers AG
18.4. GE Healthcare
18.5. MR Solutions
18.6.Aspect Imaging Ltd.
18.7.Mediso Medical Imaging Systems
18.8. MILabs B.V.
18.9.TriFoil Imaging
18.10.Agilent Technologies, Inc.
18.11. Fujifilm Holdings Corporation
18.12.Thermo Fisher Scientific Inc.
18.13.Miltenyi Biotec
18.14.LI-COR Biosciences
18.15.Perceptive Instruments Ltd.
18.16.Other Prominent Players
19. APPENDIX
20.CONSULTANT RECOMMENDATION
